Primary Ovarian Cancer Establishment Media (Ince OCMI-e) (Liquid)
Biozol Catalog Number:
USB-506389
Supplier Catalog Number:
506389
Alternative Catalog Number:
USB-506389-500
Manufacturer:
US Biological
Category:
Zellen/Zellkultur
Primary Ovarian Cancer Establishment Media (Ince) Tan A. Ince, MD, PhD - Fighting Cancer by Keeping Cancer Cells Alive ... https://www.scientia.global/tan-ince-md-phd-fighting-cancer-keeping-cancer-cells-alive/ Feb 12, 2017 - Professor Ince was a visiting clinical scientist at the Massachusetts Institute of Technology from 2000 to 2007, where he developed a new cell culture nutrient medium that is now widely used to grow human breast and ovary cells. Customer supplied: To be supplemented with 2% fetal bovine serum to media To be supplemented with Calbiochem 227036 Cholera Toxin w/o azide, 25ng/ml to media. Appearance: Red to orange, clear, complete OCMI-e Bullet 1 Included (506389B, Colorless): Supplied as a liquid. Thaw, vortex, spin down and add whole vial to 506389. OCMI-e Bullet 2 Included (506389C, Pink): Supplied as a liquid. Thaw, vortex, spin down and add whole vial to 506389. Storage (506389B, 506389C): Liquid is stable at -20C. Storage and Stability (w/o supplements): Store at 4C. Do not freeze. Light sensitive, store in the dark. Stable for 6 months w/o supplements. Storage and Stability (w/ supplements): Complete media with supplements is stable for 6 weeks at 4C. Do Not Freeze. Light sensitive, store in the dark. Country of Origin United States Customer supplied: To be supplemented with 2% fetal bovine serum to media To be supplemented with Calbiochem 227036 Cholera Toxin w/o azide, 25ng/ml to media. Important Note: Cholera toxin is NOT included in the liquid media nor the bullet. Shipping regulations have made it increasingly difficult to ship. Please procure from your local supplier. Calbiochem 227036 Cholera Toxin w/o azide, 25ng/ml to media. Licensed by TumorGenesisTM. Manufactured for research use by US Biological.
* VAT and and shipping costs not included. Errors and price changes excepted